Les syndromes parkinsoniens atypiques et secondaires

Couverture
François Tison
Elsevier Masson, 2006 - 305 pages
 

Avis des internautes - Rédiger un commentaire

Aucun commentaire n'a été trouvé aux emplacements habituels.

Table des matières

Comité scientifique
1
Conclusion
7
Éléments de la stratégie diagnostique
23
Conclusion
32
Neuroimagerie fonctionnelle Philippe Remy
52
Tests pharmacologiques et syndromes parkinsoniens
67
Explorations électrophysiologiques et oculographiques
72
Explorations du Système nerveux Autonome
92
Démence à corps de Lewy Luc Defebvre Kathy Dujardin
187
Dégénérescence cortico basale
203
Les syndromes parkinsoniens atypiques des Caraïbes
214
Neuroimagerie
222
Les syndromes parkinsoniens atypiques de transmission autosomique
230
Les syndromes parkinsoniens de transmission autosomique récessive
236
Conclusion Alain Destée
246
Syndromes parkinsoniens secondaires Causes iatrogènes
263

Troubles vésicosphinctériens et explorations du système urinaire
106
Aspects neuropsychologiques Bruno Dubois Francesca Antonelli
112
Neuropathologie des syndromes parkinsoniens atypiques
124
Conclusion Marie Vidailhet
142
Paralysie supranucléaire progressive Frédéric Macia François Viallet
167
Syndromes parkinsoniens postencéphalitiques et postinfectieux
274
Autres causes secondaires et atypiques de syndromes parkinsoniens
285
Syndromes parkinsoniens par affections métaboliques
291
Conclusion Olivier Rascol
304
Droits d'auteur

Expressions et termes fréquents

Fréquemment cités

Page 139 - Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man. including those of Parkinson's disease. Pick's disease, and Alzheimer's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and Mallory bodies in alcoholic liver disease. J. Pathol.
Page 21 - Progressive supranuclear palsy: a heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia.
Page 63 - ED, et al. Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with "C-raclopride and positron emission tomography.
Page 262 - Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181-184 Hughes AJ, Daniel SE, Lees AJ (2001) Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease.
Page 92 - Clinical features and natural history of multiple system atrophy. An analysis of 100 cases.
Page 63 - Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Ann Neurol 1990;28:547-555.
Page 141 - A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy. nuchal dystonia and dementia. Arch Neurol.
Page 63 - Burn DJ, Sawle GV, Brooks DJ. "Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data", J Neurol Neurosurg Psychiatry.
Page 138 - Graham JG, Oppenheimer DR. Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry 1969;32:28-34.
Page 34 - Neuropsychological pattern of striatonigral degeneration: Comparison with Parkinson's disease and progressive supranuclear palsy.

Informations bibliographiques